{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T14:12:10Z","timestamp":1774102330808,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ebr.2025.100836","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:59:19Z","timestamp":1762315159000},"page":"100836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Network analysis of antiseizure medication use, efficacy, and safety in epilepsy: A retrospective cohort study in a tertiary care center"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-0525","authenticated-orcid":false,"given":"Miguel Angel","family":"Morales-Morales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9737-0529","authenticated-orcid":false,"given":"Emilio","family":"Garc\u00eda-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6685-5851","authenticated-orcid":false,"given":"Daniel","family":"San-Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Trenado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Carolina","family":"Pimentel-Saona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazmin","family":"Palomares-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Alejandro","family":"Del R\u00edo-Qui\u00f1ones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica Alejandra","family":"Montalvo-H\u00e9rnandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0303-0140","authenticated-orcid":false,"given":"Christopher De","family":"Jes\u00fas-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8433-1161","authenticated-orcid":false,"given":"Jes\u00fas Iv\u00e1n","family":"Ruiz-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio","family":"Rubinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebr.2025.100836_b0005","unstructured":"Pesqueira GQ, San-Juan D, Albarr\u00e1n RH, Vazquez ML, Canales GQ, Pesqueira JG. A systematic review of the epidemiology of epilepsy in Mexico during 1970 to 2020, Arquivos de Neuro-Psiquiatria, Vol. 812023."},{"issue":"4","key":"10.1016\/j.ebr.2025.100836_b0010","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/epi.16850","article-title":"Prevalence and incidence of epilepsy in Latin America and the Caribbean: a systematic review and meta\u2010analysis of population\u2010based studies","volume":"62","author":"Alva-D\u00edaz","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100836_b0015","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024). 'Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021'. The Lancet Neurology, 23(3), pp. 344\u2013381."},{"key":"10.1016\/j.ebr.2025.100836_b0020","doi-asserted-by":"crossref","unstructured":"Kanner, A.M. et al. (2018) 'Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy', Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society, Neurology.","DOI":"10.1212\/WNL.0000000000005756"},{"issue":"4","key":"10.1016\/j.ebr.2025.100836_b0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100836_b0030","doi-asserted-by":"crossref","unstructured":"Yang Y, Yafei Shangguan, Wang X, Liu R, Shen Z, Tang M, et al. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study. Frontiers in neurology. 2024 Jan 9;14.","DOI":"10.3389\/fneur.2023.1307296"},{"key":"10.1016\/j.ebr.2025.100836_b0035","doi-asserted-by":"crossref","unstructured":"Thijs, R.D., Surges, R., O'Brien, T.J. y Sander, J.W. (2019) 'Epilepsy in adults', Lancet, 393(10172), pp. 689-701.","DOI":"10.1016\/S0140-6736(18)32596-0"},{"key":"10.1016\/j.ebr.2025.100836_b0040","doi-asserted-by":"crossref","unstructured":"Machado-Alba, J.E., Calvo-Torres, L.F., Garc\u00eda-Betancur, S., Aguirre-Novoa, A. y Ba\u00f1ol-Giraldo, A.M. (2015) 'Estudio de prescripci\u00f3n-indicaci\u00f3n en pacientes que reciben antiepil\u00e9pticos en Colombia', Neurolog\u00eda.","DOI":"10.1016\/j.nrl.2015.06.015"},{"issue":"12","key":"10.1016\/j.ebr.2025.100836_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032551","article-title":"Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records","volume":"9","author":"Powell","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ebr.2025.100836_b0050","first-page":"77","article-title":"'Trends in the first antiepileptic drug prescribed for epilepsy Seizure: European","volume":"23","author":"Pickrell","year":"2014","journal-title":"J Epilepsy"},{"key":"10.1016\/j.ebr.2025.100836_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108841","article-title":"Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: a retrospective cohort study using the database of health insurance claims between 2015 and 2019","volume":"134","author":"Jin","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.ebr.2025.100836_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00345","article-title":"Effectiveness analysis of three-drug combination therapies for refractory focal epilepsy","volume":"21","author":"Wu","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebr.2025.100836_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: Position paper of the International League against Epilepsy","author":"Beniczky","year":"2025","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ebr.2025.100836_b0070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic strategies","volume":"51","author":"Kwan","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ebr.2025.100836_b0075","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1528-1167.2011.03355.x","article-title":"Revising the \u201crule of three\u201d for inferring seizure freedom","volume":"53","author":"Westover","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100836_b0080","article-title":"Drug-resistant epilepsy: use of the new definition and related risk factors. a study in a Mexican population at a tertiary care center. Revista de","volume":"54(03):159","author":"Mart\u00ednez Ju\u00e1rez","year":"2012","journal-title":"Neurolog\u00eda"},{"issue":"1","key":"10.1016\/j.ebr.2025.100836_b0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/2041-210X.12458","article-title":"BiMat: a MATLAB package to facilitate the analysis of bipartite networks","volume":"7","author":"Flores","year":"2015","journal-title":"Methods Ecol Evol"},{"issue":"8","key":"10.1016\/j.ebr.2025.100836_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1212\/WNL.0000000000200852","article-title":"Trends in Antiseizure Medication Use","volume":"99","author":"Bensken","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.ebr.2025.100836_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1135962","article-title":"Prescription trends of antiseizure medications before and during the COVID-19 pandemic","author":"Lavu","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebr.2025.100836_b0100","doi-asserted-by":"crossref","unstructured":"Res\u00e9ndiz-Aparicio JC, Y L\u00f3pez-Vargas, G Vargas-Ram\u00edrez, J Rogel-Cuevas, Castro-Mac\u00edas JI, G Soca-Chafre, et al. Etiology of epilepsy in Mexico: results of the national multicenter registry. Revista de Neurolog\u00eda. 2024 Jan 1;79(07):199-9.","DOI":"10.33588\/rn.7907.2024107"},{"key":"10.1016\/j.ebr.2025.100836_b0105","unstructured":"Clinical practice guideline for epilepsy 2010. Neurological Society of Japan Treatment Guidelines. 2010. Available from: www.neurology-jp.org."},{"key":"10.1016\/j.ebr.2025.100836_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108666","article-title":"Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: a German longitudinal analysis from 2008 to 2020","volume":"130","author":"Hochbaum","year":"2022","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ebr.2025.100836_b0115","doi-asserted-by":"crossref","unstructured":"Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, et al. Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005. European Journal of Neurology. 2007 Sep 28;14(12):1317\u201321.","DOI":"10.1111\/j.1468-1331.2007.01970.x"},{"issue":"2","key":"10.1016\/j.ebr.2025.100836_b0120","first-page":"25","article-title":"Clinical guideline. Antiepileptic drugs of choice for focal and generalized seizures in adults","volume":"20","author":"Rivera","year":"2019","journal-title":"Revista Mexicana de Neurociencia"},{"issue":"10","key":"10.1016\/j.ebr.2025.100836_b0125","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic Acid and Epilepsy: from Molecular Mechanisms to Clinical Evidences","volume":"17","author":"Romoli","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"10.1016\/j.ebr.2025.100836_b0130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1528-1167.2012.03446.x","article-title":"Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries","volume":"53","author":"Cameron","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ebr.2025.100836_b0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-0044-1782616","article-title":"Epilepsy Care in Latin America and the Caribbean: Overcoming challenges and Embracing Opportunities","volume":"44","author":"Rubinos","year":"2024","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ebr.2025.100836_b0140","doi-asserted-by":"crossref","unstructured":"Das K, Banerjee M, Mondal GP, Devi LG, Singh OP, Mukherjee BB. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: A study in an urban epilepsy clinic in India. Seizure. 2007 Oct;16(7):601\u20137.","DOI":"10.1016\/j.seizure.2007.04.008"},{"key":"10.1016\/j.ebr.2025.100836_b0145","year":"2024","journal-title":"PAHO [Internet]"},{"issue":"2","key":"10.1016\/j.ebr.2025.100836_b0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/epi.17155","article-title":"Survey on the worldwide availability and affordability of antiseizure medications: Report of the ILAE Task Force on Access to Treatment","volume":"63","author":"Pironi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebr.2025.100836_b0155","doi-asserted-by":"crossref","unstructured":"Fikreselam Habte Hailemariam, Mekdes Shifa, Chalelgn Kassaw. Availability, price, and affordability of antiseizure medicines in Addis Ababa, Ethiopia. Epilepsia open. 2023 Jul 28;8(3):1123\u201332.","DOI":"10.1002\/epi4.12792"},{"key":"10.1016\/j.ebr.2025.100836_b0160","doi-asserted-by":"crossref","unstructured":"Mandal S, Aruna Donepudi, Jabeen Shaik Afshan, Suryaprabha Turaga. A drug utilization study of antiepileptic drugs uses in a tertiary care teaching hospital of India. International Journal of Basic & Clinical Pharmacology. 2021 Oct 22;10(11):1293\u20133.","DOI":"10.18203\/2319-2003.ijbcp20214120"},{"key":"10.1016\/j.ebr.2025.100836_b0165","doi-asserted-by":"crossref","unstructured":"Fong S, Minh\u2010An Thuy Le, Lim K, Herlyani Khosama, Ohnmar Ohnmar, Savath S, et al. Affordability of newer antiseizure medications in Asian resource\u2010limited countries. Epilepsia. 2023 May 27;64(8):2116\u201325.","DOI":"10.1111\/epi.17668"},{"key":"10.1016\/j.ebr.2025.100836_b0170","doi-asserted-by":"crossref","unstructured":"Habib M, Khan SU, Hoque MA, Mondal MBA, Hasan AH, Chowdhury RN, et al. Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital. BMC Research Notes. 2013 Nov 18;6(1).","DOI":"10.1186\/1756-0500-6-473"},{"key":"10.1016\/j.ebr.2025.100836_b0175","doi-asserted-by":"crossref","unstructured":"Ajinkya S, Fox J, Lekoubou A. Contemporary trends in antiepileptic drug treatment among women of childbearing age with epilepsy in the United States: 2004\u20132015. Journal of the Neurological Sciences. 2021 Aug;427:117500.","DOI":"10.1016\/j.jns.2021.117500"},{"issue":"12","key":"10.1016\/j.ebr.2025.100836_b0180","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.sapharm.2021.06.021","article-title":"An introduction to network analysis for studies of medication use","volume":"17","author":"Askar","year":"2021","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.ebr.2025.100836_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1211491","article-title":"Revealing the dynamic landscape of drug-drug interactions through network analysis","volume":"14","author":"Jeong","year":"2023","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ebr.2025.100836_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247018","article-title":"A landscape for drug-target interactions based on network analysis","volume":"16","author":"Galan-Vasquez","year":"2021","journal-title":"PLoS One"}],"container-title":["Epilepsy & Behavior Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589986425000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:27:08Z","timestamp":1765333628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589986425000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S2589986425000966"],"URL":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100836","relation":{},"ISSN":["2589-9864"],"issn-type":[{"value":"2589-9864","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Network analysis of antiseizure medication use, efficacy, and safety in epilepsy: A retrospective cohort study in a tertiary care center","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebr.2025.100836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100836"}}